These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 37201736)
41. The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations. Theofilis P; Oikonomou E; Tsioufis K; Tousoulis D Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298518 [TBL] [Abstract][Full Text] [Related]
42. Dynamic Role of Macrophage Sub Types on Development of Atherosclerosis and Potential Use of Herbal Immunomodulators as Imminent Therapeutic Strategy. Duraisamy P; Ravi S; Krishnan M; Livya CM; Manikandan B; Arunagirinathan K; Ramar M Cardiovasc Hematol Agents Med Chem; 2022; 20(1):2-12. PubMed ID: 33334298 [TBL] [Abstract][Full Text] [Related]
44. The role of metabolic reprogramming of oxygen-induced macrophages in the dynamic changes of atherosclerotic plaques. Shen L; Chen W; Ding J; Shu G; Chen M; Zhao Z; Xia S; Ji J FASEB J; 2023 Mar; 37(3):e22791. PubMed ID: 36723768 [TBL] [Abstract][Full Text] [Related]
45. Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques. Lewis DR; Petersen LK; York AW; Ahuja S; Chae H; Joseph LB; Rahimi S; Uhrich KE; Haser PB; Moghe PV Cardiovasc Res; 2016 Feb; 109(2):283-93. PubMed ID: 26472131 [TBL] [Abstract][Full Text] [Related]
46. Atherosclerosis as an inflammatory disease. Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643 [TBL] [Abstract][Full Text] [Related]
47. Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques. Alaarg A; Zheng KH; van der Valk FM; da Silva AE; Versloot M; van Ufford LC; Schulte DM; Storm G; Metselaar JM; Stroes ES; Hamers AA Vascul Pharmacol; 2016 Jul; 82():51-9. PubMed ID: 27189780 [TBL] [Abstract][Full Text] [Related]
48. Macrophage Plasticity and Atherosclerosis Therapy. Lin P; Ji HH; Li YJ; Guo SD Front Mol Biosci; 2021; 8():679797. PubMed ID: 34026849 [TBL] [Abstract][Full Text] [Related]
50. Integrated application of transcriptome and metabolomics reveals potential therapeutic targets for the polarization of atherosclerotic macrophages. Shen L; Li H; Chen W; Su Y; Yu J; Chen M; Shu G; Qiao E; Guo X; Xu M; Xia S; Zhao Z; Lu C; Ji J Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166550. PubMed ID: 36150660 [TBL] [Abstract][Full Text] [Related]
51. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice. Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554 [TBL] [Abstract][Full Text] [Related]
52. Homocysteine accelerates atherosclerosis via inhibiting LXRα-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages. Jin P; Bian Y; Wang K; Cong G; Yan R; Sha Y; Ma X; Zhou J; Yuan Z; Jia S Life Sci; 2018 Dec; 214():41-50. PubMed ID: 30393020 [TBL] [Abstract][Full Text] [Related]
53. Immunometabolism and immune response regulate macrophage function in atherosclerosis. Xue S; Su Z; Liu D Ageing Res Rev; 2023 Sep; 90():101993. PubMed ID: 37379970 [TBL] [Abstract][Full Text] [Related]
54. Oxysterol mixture and, in particular, 27-hydroxycholesterol drive M2 polarization of human macrophages. Marengo B; Bellora F; Ricciarelli R; De Ciucis C; Furfaro A; Leardi R; Colla R; Pacini D; Traverso N; Moretta A; Pronzato MA; Bottino C; Domenicotti C Biofactors; 2016; 42(1):80-92. PubMed ID: 26669587 [TBL] [Abstract][Full Text] [Related]
55. Macrophage Lxrα reduces atherosclerosis in Ldlr Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671 [TBL] [Abstract][Full Text] [Related]
57. Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis. Gao C; Liu C; Chen Q; Wang Y; Kwong CHT; Wang Q; Xie B; Lee SMY; Wang R J Control Release; 2022 Sep; 349():2-15. PubMed ID: 35779655 [TBL] [Abstract][Full Text] [Related]
58. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis. Gong M; Zhuo X; Ma A Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615 [TBL] [Abstract][Full Text] [Related]
59. Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis. Poznyak AV; Kashirskikh DA; Sukhorukov VN; Kalmykov V; Omelchenko AV; Orekhov AN Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163256 [TBL] [Abstract][Full Text] [Related]
60. Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE Zhou Y; Chen R; Liu D; Wu C; Guo P; Lin W Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29135917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]